In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``National Institute on Minority 
Health Act''.

SEC. 2. FINDINGS.

The Congress finds that--
            (1) heart disease and strokes lead to about 2\1/2\ times as 
        many deaths among Black Americans (between the ages of 25 and 
        44) as among White Americans;
            (2) diabetes is twice as prevalent among Mexican- and 
        Puerto Rican-Americans as among White Americans;
            (3) Black and Hispanic women account for 73 percent of the 
        reported cases of AIDS among American women, and the death rate 
        from AIDS is 9 times higher among Black women than among White 
        women;
            (4) between 1983 and 1985, when the infant mortality rate 
        among Whites was 9.0 deaths per 1,000 live births, the infant 
        mortality rate among Blacks was 18.7 and 13.9 among Native 
        Americans, with similar disparities among rates of low-
        birthweight babies;
            (5) in 1988, when the rates of death resulting from 
        homicides was 8 per 100,000 among young (ages 15 to 24) White 
        males, the rate among young Black males was 59 per 100,000, and 
        the rates for young Hispanic and Native American males was 
        roughly 2 to 3 times that of young White males;
            (6) biomedical research, including clinical trials for 
        pharmaceuticals, often has failed to include minorities in the 
        population being studied or tested, even when it is certain 
        that minorities will be among the population subject to the 
        medical condition or receiving the treatment or pharmaceutical 
        that is being studied or tested;
            (7) the percentages of medical professionals, especially 
        physicians, who are minorities are significantly lower than 
        their representation in the general population; and
            (8) the ratio of physicians to inhabitants of neighborhoods 
        that are heavily populated by minorities (or low-income 
        residents) is often much lower than the ratio of physicians to 
        inhabitants of predominantly White neighborhoods.

SEC. 3. ESTABLISHMENT OF NATIONAL INSTITUTE ON MINORITY HEALTH.

    Part C of title IV of the Public Health Service Act (42 U.S.C. 285 
et seq.), as amended by section 124 of Public Law 102-321 (106 Stat. 
364), is amended by adding at the end the following subpart:

          ``Subpart 17--National Institute on Minority Health

                         ``purpose of institute

    ``Sec. 464V. (a) The general purpose of the National Institute on 
Minority Health is the conduct and support of research, training, the 
dissemination of health information, and other programs with respect to 
minority health conditions, including the advancement of opportunities 
for and recruitment of minorities for training and placement as health 
professionals.
    ``(b) For purposes of this subpart:
            ``(1) The term `health care system' means the system in the 
        United States for the delivery of health care.
            ``(2) The term `minorities' means members of minority 
        groups.
            ``(3) The term `minority health conditions' means all 
        diseases, disorders, and conditions (including conditions 
        regarding mental health)--
                    ``(A) unique to, more serious in, or more prevalent 
                in minorities;
                    ``(B) for which the factors of medical risk or 
                types of medical intervention are different for 
                minorities, or for which it is unknown whether such 
                factors or types are different for minorities; or
                    ``(C) with respect to which there has been 
                insufficient clinical research involving minorities as 
                subjects, or insufficient clinical data on minorities.
            ``(4) The term `research on minority health' means research 
        on minority health conditions.
            ``(5) The term `Institute' means the National Institute on 
        Minority Health.

                         ``certain authorities

    ``Sec. 464W. (a) In carrying out section 464V, the Director of the 
Institute shall--
            ``(1) recommend an agenda for conducting and supporting 
        research on minority health;
            ``(2) identify projects of research on minority health that 
        should be conducted or supported by the national research 
        institutes;
            ``(3) identify multidisciplinary research relating to 
        research on minority health that should be so conducted or 
        supported;
            ``(4) promote coordination and collaboration among entities 
        conducting research identified under paragraph (2) or (3);
            ``(5) encourage the conduct of research identified under 
        paragraph (2) or (3) by entities receiving funds from the 
        national research institutes;
            ``(6) ensure that minorities are appropriately represented 
        as subjects in projects of clinical research conducted or 
        supported by the national research institutes and, as 
        appropriate, encourage similar representation in research 
        conducted under other circumstances; and
            ``(7) promote the sufficient allocation of the resources of 
        the national research institutes for conducting and supporting 
        such research.
    ``(b)(1) The Director of the Institute shall monitor the health 
care system for the purpose of determining the effects of the system on 
the health of minorities, including the extent to which minorities have 
access to health care. In monitoring the system, the Director shall 
determine, with respect to such purpose, the effects of the policies 
and practices of entities that provide health benefits plans.
    ``(2) With respect to Federal proposals for reforming the health 
care system, the Director of the Institute shall, in carrying out 
paragraph (1), monitor such proposals for the purpose of determining 
whether the proposals adequately provide for the health of minorities.
    ``(c)(1) The Director of the Institute shall serve as an advocate 
regarding the health of minorities. The Director may in so serving 
carry out advocacy activities regarding the Federal Government, State 
and local governments, and private entities, including public and 
private educational entities.
    ``(2) In carrying out paragraph (1), the Director of the Institute 
shall determine the health benefits for minorities that should, at a 
minimum, be provided for in any reform of the health care system.
    ``(d) The Director of the Institute shall encourage the creation of 
opportunities for the training of minorities as health professionals 
and shall facilitate the placement of minorities trained as health 
professionals into appropriate positions.''.

SEC. 4. CONFORMING AMENDMENT.

    Section 401(b)(1) of the Public Health Service Act (42 U.S.C. 
281(b)(1)), as amended by section 121 of Public Law 102-321 (106 Stat. 
358), is amended by adding at the end the following subparagraph:
            ``(Q) The National Institute on Minority Health.''.
National Institute on Minority Health Act - Amends the Public Health Service Act to declare that the National Institute on Minority Health's purpose is the conduct and support of research, training, information dissemination, and other programs regarding minority health, including the advancement of opportunities for and recruitment of minorities for training and placement as health professionals.  Adds the Institute to the list of research institutes of the National Institutes of Health.

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Empowering Parents and Teachers for 
a Drug-Free Education Act of 2004''.

SEC. 2. FINDINGS.

    The Congress finds as follows:
            (1) Fifty-four percent of high school seniors in 2001 had 
        used an illicit drug in their lifetime.
            (2) Forty-two percent of 12th graders, 37 percent of 10th 
        graders, and 20 percent of 8th graders in 2001 had used an 
        illicit drug in the past year.
            (3) Eighty percent of 12th graders, 70 percent of 10th 
        graders, and 51 percent of 8th graders in 2001 had used alcohol 
        in their lifetime.
            (4) Sixty-four percent of 12th graders, 48 percent of 10th 
        graders, and 23 percent of 8th graders in 2001 had been 
        intoxicated.
            (5) Use of 3,4-methylenedioxy methamphetamine (commonly 
        referred to as ``MDMA'' or ``ecstasy'') by 12th graders 
        increased from 6 percent in 1998 to 11.7 percent in 2001.
            (6) Schoolchildren who use and abuse addictive illicit 
        drugs or alcohol increase the risk to the health and safety of 
        all students and impact the learning environment of the school 
        because--
                    (A) use of illicit drugs or alcohol can lead to 
                serious health effects, the development of life-
                threatening diseases, and even death;
                    (B) use of illicit drugs like marijuana or ecstasy 
                kills brain cells in the learning centers of the brain, 
                directly impacting a student's ability to learn in 
                school;
                    (C) chemicals left in the central nervous system 
                after using marijuana cause the brain to be irritated 
                and uncontrollable, resulting in disruptive behavior in 
                the classroom;
                    (D) students who smoke cigarettes or use other 
                illicit drugs have been shown to have less desire to 
                learn, resulting in lower grade point averages when 
                compared to other students; and
                    (E) students who use illicit drugs or alcohol have 
                a higher rate of breaking school rules.

SEC. 3. DRUG-FREE SCHOOL DEMONSTRATION PROGRAMS.

    (a) Demonstration Programs.--Part A of title IV of the Elementary 
and Secondary Education Act of 1965 (20 U.S.C. 7101 et seq.; also known 
as the ``Safe and Drug-Free Schools and Communities Act'') is amended--
            (1) by redesignating subpart 4 as subpart 5; and
            (2) by inserting after subpart 3 the following:

          ``Subpart 4--Drug-Free School Demonstration Programs

``SEC. 4145. DRUG-FREE SCHOOL DEMONSTRATION PROGRAMS.

    ``(a) Grants.--The Secretary may make grants to local educational 
agencies and private schools to establish drug-free school 
demonstration programs described in subsection (b).
    ``(b) Requirements.--A grant may be made under subsection (a) only 
if the local educational agency or private school involved agrees to 
use the funds received under the grant to establish a drug-free school 
demonstration program that--
            ``(1) includes, consistent with the fourth amendment to the 
        Constitution of the United States, random drug testing of 
        students;
            ``(2) requires that any such testing be conducted using 
        only drug tests approved by the Food and Drug Administration;
            ``(3) requires that any analysis of such testing be 
        conducted by a drug-testing laboratory certified by the 
        Substance Abuse and Mental Health Services Administration, or 
        approved by the College of American Pathologists, for forensic 
        drug testing;
            ``(4) requires a review of each positive test result by a 
        medical review officer;
            ``(5) prohibits any disclosure to law enforcement officials 
        of the results of the random drug testing;
            ``(6) requires that drug-testing records be kept strictly 
        confidential in accordance with subsection (c);
            ``(7) requires, upon the submission of a report by a 
        medical review officer under subsection (c)(3) relating to a 
        preliminary positive test result, the destruction of all 
        records relating to the result if the medical review officer 
        does not confirm the result;
            ``(8) requires the destruction of all records relating to 
        drug or alcohol testing of a student when the student graduates 
        or otherwise leaves the local educational agency or private 
        school involved;
            ``(9) ensures that the parents of the students to be tested 
        are informed in detail about the random drug-testing program;
            ``(10) provides parents the right to withdraw their child 
        from participation in the random drug-testing program, and 
        ensures that parents receive notification of such right at the 
        beginning of every school year;
            ``(11) includes a clear, written policy on school behavior 
        that--
                    ``(A) prohibits students from attending school or 
                school activities under the influence of illegal drugs 
                or alcohol;
                    ``(B) prohibits the use or possession of illegal 
                drugs in school; and
                    ``(C) sets forth the consequences of violating the 
                prohibitions described in subparagraphs (A) and (B);
            ``(12) provides drug and alcohol abuse prevention training 
        for a total of not less than 2 hours for each student and staff 
        member of the local educational agency or private school 
        involved;
            ``(13) provides student access to a student assistance 
        program, including confidential assessment, referral, and 
        short-term problem resolution; and
            ``(14) provides continuing alcohol, tobacco, and drug abuse 
        prevention education.
    ``(c) Privacy Protection.--Each drug-free school demonstration 
program established with assistance made available under this section 
shall--
            ``(1) include, as reasonably necessary and appropriate, 
        practices and procedures to ensure the confidentiality of 
        student drug test results and of any participation by a student 
        in a treatment or rehabilitation program;
            ``(2) prohibit the mandatory disclosure of medical 
        information by a student unless the student tests positive for 
        drugs; and
            ``(3) require a medical review officer reviewing student 
        drug test results to report the final results of such tests in 
        writing and in a manner designed to ensure the confidentiality 
        of the results.
    ``(d) Technical Assistance.--To the extent or in the amounts 
provided in advance in appropriations Acts, the Secretary may enter 
into contracts with public and private entities to provide assistance 
related to carrying out the drug-free school demonstration programs 
established pursuant to this section.
    ``(e) Applications.--To seek a grant under this section, a local 
educational agency or private school shall submit an application to the 
Secretary at such time, in such manner, and containing such information 
as the Secretary may require.
    ``(f) Definitions.--For purposes of this section:
            ``(1) The term `medical review officer'--
                    ``(A) means a licensed physician with knowledge of 
                substance abuse disorders; and
                    ``(B) does not include any--
                            ``(i) employee of the school involved; or
                            ``(ii) employee or agent of, or any person 
                        having a financial interest in, the laboratory 
                        for which the drug test results are being 
                        reviewed.
            ``(2) The term `student' means any individual enrolled on 
        school records as eligible to attend, or actually attending, 
        school for educational purposes in any of grades 8 through 
        12.''.
    (b) Report.--Not later than 18 months after the date of the 
enactment of this Act, the Secretary of Education shall submit to the 
Congress a report on the results of the drug-free school demonstration 
programs established with assistance under this section.
    (c) Authorization of Appropriations.--Section 4003 of the 
Elementary and Secondary Education Act of 1965 (20 U.S.C. 7103) is 
amended--
            (1) in paragraph (1), by striking ``and'' at the end;
            (2) in paragraph (2), by striking the period at the end and 
        inserting ``; and''; and
            (3) by adding at the end the following:
            ``(3) $25,000,000 for fiscal year 2005, and for each of 
        fiscal years 2006 and 2007, for drug-free school demonstration 
        programs under subpart 4.''.
    (d) Conforming Amendment.--The table of contents at section 2 of 
the Elementary and Secondary Education Act of 1965 is amended--
            (1) by redesignating the item relating to subpart 4 of part 
        A of title IV as the item relating to subpart 5 of part A of 
        title IV; and
            (2) by inserting after the item relating to section 4141 
        the following:

          ``subpart 4--drug-free school demonstration programs
``4145. Drug-free school demonstration programs.''.
Empowering Parents and Teachers for a Drug-Free Education Act of 2004 - Amends the Elementary and Secondary Education Act of 1965 (under provisions which are also known as the Safe and Drug-Free Schools and Communities Act) to authorize the Secretary of Education to make grants to local educational agencies and private schools to establish drug-free school demonstration programs that include random drug testing of students and meet other specified requirements.

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Building Innovation Growth through 
Data for Intellectual Property Act'' or the ``BIG Data for IP Act''.

SEC. 2. DEFINITIONS.

    In this Act--
            (1) the term ``advanced data science analytics'' means 
        techniques, such as artificial intelligence, machine learning, 
        and other methods of analyzing large data sets, that are used 
        to make policy recommendations;
            (2) the term ``Director'' means the Under Secretary of 
        Commerce for Intellectual Property and Director of the Office;
            (3) the term ``Office'' means the United States Patent and 
        Trademark Office;
            (4) the term ``PPAC'' means the Patent Public Advisory 
        Committee of the Office; and
            (5) the term ``TPAC'' means the Trademark Public Advisory 
        Committee of the Office.

SEC. 3. FINDINGS.

    Congress finds the following:
            (1) Section 10(a) of the Leahy-Smith America Invents Act 
        (35 U.S.C. 41 note) grants the Director the authority to ``set 
        or adjust by rule any fee established, authorized, or charged 
        under title 35, United States Code, or the Trademark Act of 
        1946. . . . to recover the aggregate estimated costs to the 
        Office for processing, activities, services, and materials 
        relating to patents (in the case of patent fees) and trademarks 
        (in the case of trademark fees), including administrative costs 
        of the Office''.
            (2) The Office has worked with PPAC, TPAC, and the public 
        to engage in a fee-setting process that is transparent, as 
        envisioned by the Leahy-Smith America Invents Act (Public Law 
        112-29; 125 Stat. 284).
            (3) Since 2011, the Office has used this fee-setting 
        authority to implement a sustainable funding model with an 
        operating reserve, which allows the Office to invest in long-
        term projects, including crucial infrastructure upgrades that 
        are necessary for a 21st century intellectual property office, 
        regardless of whether there are temporary fluctuations in 
        patent or trademark filings.
            (4) The infrastructure upgrades described in paragraph (3) 
        include the use of advanced data science analytics, which will 
        help to--
                    (A) improve productivity and quality with respect 
                to the issuance of patents and trademarks; and
                    (B) ensure--
                            (i) the consistent application of laws by 
                        nearly 9,000 patent examiners and trademark 
                        examining attorneys; and
                            (ii) the certainty and strength of 
                        Federally-granted rights that are foundational 
                        to the economy of the United States.

SEC. 4. EXTENSION OF SUNSET.

    Section 10(i)(2) of the Leahy-Smith America Invents Act (35 U.S.C. 
41 note) is amended by striking ``the 7-year period beginning on the 
date of the enactment of this Act'' and inserting ``the 10-year period 
beginning on the date of enactment of the BIG Data for IP Act''.

SEC. 5. REPORT.

    Not later than 2 years after the date of enactment of this Act, the 
Director shall submit to Congress a report that includes--
            (1) the status of the capabilities of the information 
        technology systems of the Office with respect to--
                    (A) the examination of patents and trademarks; and
                    (B) proceedings conducted before the--
                            (i) Patent Trial and Appeal Board of the 
                        Office; and
                            (ii) Trademark Trial and Appeal Board of 
                        the Office;
            (2) a 5-year plan for further modernization of the 
        information technology systems described in paragraph (1); and
            (3) an accounting of the use by the Office of advanced data 
        science analytics, including from commercially available 
        sources, to improve the patent and trademark examination 
        process where appropriate, including--
                    (A) a description of how the Office uses advanced 
                data science analytics with respect to the examination 
                of patents and trademarks to--
                            (i) improve consistency;
                            (ii) detect common sources of error; and
                            (iii) improve productivity;
                    (B) a 5-year plan for further development of 
                advanced data science analytics for the uses described 
                in subparagraph (A); and
                    (C) a description of how the findings made as a 
                result of the uses of advanced data science analytics 
                under subparagraph (A) shall be made available to the 
                public on a regular basis.

Building Innovation Growth through Data for Intellectual Property Act or the BIG Data for IP Act This bill amends the Leahy-Smith America Invents Act to extend for 10 years the authority of the U.S. Patent and Trademark Office to set and adjust patent fees.